In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...
The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant ...
Zacks Investment Research on MSN
GSK's Jemperli delivers promising interim data in rectal cancer
GSK plc GSK has announced positive interim data from a mid-stage study evaluating its oncology drug, Jemperli (dostarlimab), ...
A total of 23 studies from 11 registries in eight countries spanning Europe, North America, and Oceania were identified and included in the review. Most studies were retrospective in nature and ...
New findings in a report led by the American Cancer Society (ACS) reveal an urgent picture of a growing global cancer burden ...
Earlier this week, the American Cancer Society (ACS) published its annual report in CA: A Cancer Journal for Clinicians. Each year, a team of doctors and researchers provides a comprehensive outlook ...
Source: Getty Images Breast cancer is the second most common cancer affecting American women and the second leading cause of cancer death in women. These numbers are higher than estimates from 2023, ...
Behind the gray front door of the white Cape Cod, a woman battles breast cancer. She lost her husband to colon and duodenal cancer earlier this year. A few blocks away, even closer to the contaminated ...
In the weeks around the 2026 annual meeting of the American Society of Clinical Oncology, my phone kept buzzing with alerts ...
“1 in 20 Iowans have had a diagnosis of cancer in their lifetime, and if the trends continue, we’re headed towards one in 10.” Dr. Mary Charlton, Director of the Iowa Cancer Registry SIOUX CITY (KTIV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results